Evidence map›Paper›PMID 41754994›Full record

ArticlePharmaceutics2026

Preparation and Antitumor Activity Evaluation of Folic Acid-Modified Phospholipid-Gambogic Acid Nanocrystals.

Xiwen Zeng, Sizhuo Liu, Qianhui He, Yanwen Ling, Jingqi Sun, Yang Ping, Jin Su

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiwen ZengDepartment of Pharmaceutics, School of Pharmacy, China Jiamusi University, Jiamusi 154007, China.
Sizhuo LiuDepartment of Pharmaceutics, School of Pharmacy, China Jiamusi University, Jiamusi 154007, China.
Qianhui HeDepartment of Pharmaceutics, School of Pharmacy, China Jiamusi University, Jiamusi 154007, China.
Yanwen LingDepartment of Pharmaceutics, School of Pharmacy, China Jiamusi University, Jiamusi 154007, China.
Jingqi SunDepartment of Pharmaceutics, School of Pharmacy, China Jiamusi University, Jiamusi 154007, China.ORCID 0009-0008-4674-743X
Yang PingDepartment of Pharmaceutics, School of Pharmacy, China Jiamusi University, Jiamusi 154007, China.
Jin SuDepartment of Pharmaceutics, School of Pharmacy, China Jiamusi University, Jiamusi 154007, China.

Funding

Heilongjiang Province North Medicine and Functional Food Characteristics Subject HLJTSXK-2022-03Heilongjiang Provincial Key Laboratory Fund of New Drug Development and Evaluation of Toxicology kfkt 2023-05Heilongjiang Provincial Natural Science Foundation of China LH2024H003National College Student Innovation and Entrepreneurship Training Program 202510222166The Basic Research Support Program for Excellent Young Teachers in Heilongjiang Province YQJH2023216
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

folic acid modificationgambogic acidhepatocellular carcinomananocrystalstumor-targeted therapy

Identifiers

PMID41754994
PMCPMC12944240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.